References
Spinal Cord Injury Facts and Figures at a Glance, The
National SCI Statistical Center, https://www.nscisc.
uab.edu/reports.aspx, (2017).
Sadaka F, Naydenov SK and Ponzillo JJ. Theophylline
for bradycardia secondary to cervical spinal cord
injury. Neurocrit. Care (2010) 13: 389–92.
Krassioukov A, Eng JJ, Warburton DE and Teasell
R. Spinal cord injury rehabilitation evidence research
team. A systematic review of the management of
orthostatic hypotension after spinal cord injury. Arch.
Phys. Med. Rehabil. (2009) 90: 876-85.
Fehlings MG, Tetreault LA, Wilson JR, Kwon BK,
Burns AS, Martin AR, Hawryluk G and Harrop JS.
A Clinical practice guideline for the management of
(1)
(2)
(3)
(4)
acute spinal cord injury: introduction, rationale, and
scope. Global Spine J. (2017) 7: 84-94
Pasnoori VR and Leesar MA. Use of aminophylline
in the treatment of severe symptomatic bradycardia
resistant to atropine. Cardiol. Rev. (2004) 12: 65-8.
Schulz-Stübner S. The use of small-dose theophylline
for the treatment of bradycardia in patients with spinal
cord injury. Anesth. Analg. (2005) 101: 1809-11.
Sakamoto T, Sadanaga T and Okazaki T. Sequential use
of aminophylline and theophylline for the treatment of
atropine-resistant bradycardia after spinal cord injury:
a case report. J. Cardiol. (2007) 4: 91-6.
Whitman CB, Schroeder WS, Ploch PJ and
Raghavendran K. Efficacy of aminophylline for
treatment of recurrent symptomatic bradycardia after
spinal cord injury. Pharmacotherapy (2008) 28: 131-5.
Weant KA, Kilpatrick M and Jaikumar S.
Aminophylline for the treatment of symptomatic
bradycardia and asystole secondary to cervical spine
injury. Neurocrit. Care (2007) 7: 250–2.
Nieshoff EC, Birk TJ, Birk CA, Hinderer SR and
Yavuzer G. Double-blinded, placebo-controlled trial
of midodrine for exercise performance enhancement in
tetraplegia: a pilot study. J. Spinal Cord Med. (2004)
27: 219-25.
Senard JM, Arias A, Berlan M, Tran MA, Rascol A and
Montastruc JL. Pharmacological evidence of alpha 1-
and alpha 2-adrenergic supersensitivity in orthostatic
hypotension due to spinal cord injury: a case report.
Eur. J. Clin. Pharmacol. (1991) 41: 593-6.
Barber DB, Rogers SJ, Fredrickson MD and Able
AC. Midodrine hydrochloride and the treatment of
orthostatic hypotension in tetraplegia: two cases and
a review of the literature. Spinal Cord (2000) 38:
109-11.
Mukand J, Karlin L, Barrs K and Lublin P. Midodrine
for the management of orthostatic hypotension in
patients with spinal cord injury: A case report. Arch.
Phys. Med. Rehabil. (2001) 82: 694-6.
Wecht JM, Rosado Rivera D, Handrakis JP, Radulovic
M and Bauman WA. Effects of midodrine hydrochloride
on blood pressure and cerebral blood flow during
orthostasis in persons with chronic tetraplegia. Arch.
Phys. Med. Rehabil. (2010) 91: 1429-35.
Phillips AA, Krassioukov AV, Ainslie PN and
Warburton DE. Perturbed and spontaneous regional
cerebral blood flow responses to changes in blood
pressure after high-level spinal cord injury: the effect
of midodrine. J. Appl. Physiol. (2014) 116: 645-53.